Contribution of Kv channels to phenotypic remodeling of human uterine artery smooth muscle cells

Circulation Research

Volumn 97, Issue 12, 2005, Pages 1280-1287

  Miguel Velado, Eduardo ^a   Moreno Domínguez, Alejandro ^a   Colinas, Olaia ^a   Cidad, Pilar ^a   Heras, Magda ^b   Pérez García, M Teresa ^b   López López, José Ramón ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cell proliferation; K+ currents; Kv channel expression; Vascular smooth muscle cells

Indexed keywords

CORREOLIDE; MESSENGER RNA; PAXILLINE; POTASSIUM CHANNEL KV3.4; SHAKER POTASSIUM CHANNEL; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; KCNC4 PROTEIN, HUMAN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PROTEIN SUBUNIT; SHAL POTASSIUM CHANNEL; SHAW POTASSIUM CHANNEL; TRITERPENE;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE STEADY POTENTIAL; PHENOTYPE; PHENOTYPE REMODELING; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UTERINE ARTERY; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; PHYSIOLOGY; UTERUS; VASCULARIZATION;

CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN SUBUNITS; RNA, MESSENGER; SHAKER SUPERFAMILY OF POTASSIUM CHANNELS; SHAL POTASSIUM CHANNELS; SHAW POTASSIUM CHANNELS; TETRAETHYLAMMONIUM COMPOUNDS; TRITERPENES; UTERUS;

EID: 31144448446     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000194322.91255.13     Document Type: Article

References (47)

1. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
2. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol. 1995;268:C799-C822.
3. Neylon CB. Potassium channels and vascular proliferation. Vascul Pharmacol. 2002;38:35-41.
4. Jackson WF. Ion channels and vascular tone. Hypertension. 2000;35:173.
5. Michelakis ED, Reeve HL, Huang JM, Tolarova S, Nelson DP, Weir EK, Archer SL. Potassium channel diversity in vascular smooth muscle cells. Can J Physiol Pharmacol. 1997;75:889-897.
6. Pauly RR, Bilato C, Sollott SJ, Monticone R, Kelly PT, Lakatta EG, Crow MT. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation. 1995;91:1107-1115.
7. Landsberg JW, Yuan JXJ. Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. News Physiol Sci. 2004;19:44-50.
8. Pulver RA, Rose-Curtis P, Roe MW, Wellman GC, Lounsbury KM. Store-operated Ca2+ entry activates the CREB transcription factor in vascular smooth muscle. Circ Res. 2004;94:1351-1358.
9. Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membr Biol. 1996;154:91-107.
10. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology. 2004;19:285-292.
11. Archer SL. Diversity of phenotype and function of vascular smooth muscle cells. J Lab Clin Med. 1996;127:524-529.
12. Mandegar M, Yuan JX. Role of K+ channels in pulmonary hypertension. Vascul Pharmacol. 2002;38:25-33.
13. Archer S, Rich S. Primary pulmonary hypertension: a vascular biology and translational research "work in progress". Circulation. 2000;102:2781-2791.
14. Li G, Cheung DW. Effects of paxilline on K+ channels in rat mesenteric arterial cells. Eur J Pharmacol. 1999;372:103-107.
15. Tammaro P, Smith AL, Hutchings SR, Smirnov SV. Pharmacological evidence for a key role of voltage-gated K+ channels in the function of rat aortic smooth muscle cells. Br J Pharmacol. 2004;143:303-317.
16. Cox RH, Zhou Z, Tulenko TN. Voltage-gated sodium channels in human aortic smooth muscle cells. J Vasc Res. 1998;35:310-317.
17. Belevych AE, Beck R, Tammaro P, Poston L, Smirnov SV. Developmental changes in the functional characteristics and expression of voltage-gated K+ channel currents in rat aortic myocytes. Cardiovasc Res. 2002;54:152-161.
18. Hanner M, Schmalhofer WA, Green B, Bordallo C, Liu J, Slaughter RS, Kaczorowski GJ, Garcia ML. Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affinity interaction. J Biol Chem. 1999;274:25237-25244.
19. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Moreno H, Nadal MS, Ozaita A, Pountney D, Saganich M, Vega-Saenz de Miera E, Rudy B. Molecular diversity of K+ channels. Ann N Y Acad Sci. 1999; 868:233-285.
20. Sanguinetti MC, Johnson JH, Hammerland LG, Kelbaugh PR, Volkmann RA, Saccomano NA, Mueller AL. Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. Mol Pharmacol. 1997;51:491-498.
21. Diochot S, Drici MD, Moinier D, Fink M, Lazdunski M. Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesis. Br J Pharmacol. 1999;126:251-263.
22. Kotecha SA, Schlichter LC. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J Neurosci. 1999;19:10680-10693.
23. Brevnova EE, Platoshyn O, Zhang S, Yuan JXJ. Overexpression of human KCNA5 increases IK(V) and enhances apoptosis. Am J Physiol Cell Physiol. 2004;287:C715-C722.
24. Platoshyn O, Yu Y, Golovina VA, McDaniel SS, Krick S, Li L, Wang JY, Rubin L, Yuan JXJ. Chronic hypoxia decreases KV channel expression and function in pulmonary artery myocytes. Am J Physiol. 2001;280:L801-L812.
25. Sweeney M, Yuan J. Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels. Respir Res. 2000;1:40-48.
26. Michelakis ED, Weir EK. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels. Clin Chest Med. 2001;22:419-432.
27. Thebaud B, Michelakis ED, Wu XC, Moudgil R, Kuzyk M, Dyck JR, Harry G, Hashimoto K, Haromy A, Rebeyka I, Archer SL. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation. 2004;110:1372-1379.
28. Cox RH. Changes in the expression and function of arterial potassium channels during hypertension. Vascul Pharmacol. 2002;38:13-23.
29. Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Microcirculation. 2002;9:243-257.
30. Cox RH. Molecular determinants of voltage-gated potassium currents in vascular smooth muscle. Cell Biochem Biophys. 2005;42:167-196.
31. Heusser K, Schwappach B. Trafficking of potassium channels. Curr Opin Neurobiol. 2005;15:364-369.
32. Cheong A, Quinn K, Dedman AM, Beech DJ. Activation thresholds of K-v, BK and Cl-Ca channels in smooth muscle cells in pial precapillary arterioles. J Vasc Res. 2002;39:122-130.
33. Fountain SJ, Cheong A, Flemming R, Mair L, Sivaprasadarao A, Beech DJ. Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle. J Physiol. 2004;556:29-42.
34. Albarwani S, Nemetz LT, Madden JA, Tobin AA, England SK, Pratt PF, Rusch NJ. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels. J Physiol. 2003;551:751-763.
35. Fergus DJ, Martens JR, England SK. Kv channel subunits that contribute to voltage-gated K+ current in renal vascular smooth muscle. Pflugers Arch. 2003;445:697-704.
36. Plane F, Johnson R, Kerr P, Wiehler W, Thorneloe K, Ishii K, Chen T, Cole W. Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter. Circ Res. 2005;96:216-224.
37. Cheong A, Dedman AM, Xu SZ, Beech DJ. K-v alpha 1 channels in murine arterioles: differential cellular expression and regulation of diameter. Am J Physiol Heart Circ Physiol. 2001;281:H1057-H1065.
38. Xu C, Lu Y, Tang G, Wang R. Expression of voltage-dependent K+ channel genes in mesenteric artery smooth muscle cells. Am J Physiol Gastrointest Liver Physiol. 1999;277:G1055-G1063.
39. Birnbaum SG, Varga AW, Yuan LL, Anderson AE, Sweatt JD, Schrader LA. Structure and function of Kv4-family transient potassium channels. Physiol Rev. 2004;84:803-833.
40. DeCoursey TE, Chandy KG, Gupta S, Cahalan MD. Voltage-gated K+ channels in human lymphocyte-T: a role in mitogenesis? Nature. 1984;307:465-468.
41. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH. Molecular cloning and characterization of the intermediate-conductance Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship between K(Ca) channel diversity and smooth muscle cell function. Circ Res. 1999;85:e33-e43.
42. Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A, Grgic I, Kampfe D, Si H, Wibawa J, Real R, Borner K, Brakemeier S, Orzechowski HD, Reusch HP, Paul M, Chandy KG, Hoyer J. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation. 2003;108:1119-1125.
43. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S, Stuhmer W. Oncogenic potential of EAG K(+) channels. EMBO J. 1999;18:5540-5547.
44. Kuga T, Kobayashi S, Hirakawa Y, Kanaide H, Takeshita A. Cell cycle-dependent expression of L- and T-type Ca2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res. 1996;79:14-19.
45. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC, Haller H. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J. 1998;12:593-601.
46. Rodman DM, Reese K, Harral J, Fouty B, Wu S, West J, Hoedt-Miller M, Tada Y, Li KX, Cool C, Fagan K, Cribbs L. Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ Res. 2005;96:864-872.
47. Chae KS, Dryer SE. The p38 mitogen-activated protein kinase pathway negatively regulates Ca2+-activated K+ channel trafficking in developing parasympathetic neurons. J Neurochem. 2005;94:367-379.